Month: August 2023

TORONTO, Aug. 15, 2023 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or “Company “) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products, is pleased announce the filing of interim financial statements for the three-month period ending June 30, 2023 (“Q2 2023”).   Aras Azadian, CEO stated, “We are pleased to present the results of the second quarter and report the progress of our operations, which includes the increase in revenues and improvements in margins. During the quarter we worded towards the closing of the acquisition of the Medical Cannabis by Shoppers business and prepared for the launch of the new medical cannabis care platform, MyMedi.ca, and continued to make advancements in our Canadian operations...

MANAGEMENT REPORT CEO summary Q2 2023 marks as a continuation of the newly started developments of AS Pro Kapital Grupp.  Real estate development In Tallinn, the decision taken earlier in the year on starting the construction and sales of Kalaranna 8 last stage, has proven to be the right one. As a reminder, this last and final stage consists of 4 residential buildings with 146 apartments and 4 commercial units.  Furthermore, the decision on taking on the construction management in-house has proven to be the right step.  The general contractors to this date seem to be suffering from the consequences of pandemic and the war and their pricing is simply not competitive vis-à-vis smaller contractors that we are able to engage directly. To date we have bought out the excavation/retainage works, underground monolithic concrete works and some...

Completed dosing in first cohort of Phase 1/2 GALILEO-1 trial of FLT201 in Gaucher disease; expect to report initial clinical data in third quarter of 2023 Extending impact of its novel GCase variant with research program for GBA1-linked Parkinson’s disease Management to host conference call at 8:00 a.m. ET today LONDON, Aug. 15, 2023 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today reported financial results for the second quarter of 2023 and provided a business update. “FLT201 is a potential first- and best-in-class gene therapy for Gaucher disease Type 1, the most common type of the disease,” said Michael Parini, Chief Executive Officer of Freeline. “Advancing the program is our top strategic priority, and we are extremely pleased with our recent progress and the momentum in the trial. The completion...

Conference Call to be Held Today at 8:30 A.M. ET HOUSTON, Aug. 15, 2023 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced its financial results for the second quarter ended June 30, 2023 and provided an update on recent corporate developments. “Our clinical progress this quarter was highlighted by the compelling interim results from Stage 2 of our Phase 2 study of prexigebersen as a treatment for acute myeloid leukemia, a blood cancer for which there are limited treatment options and for which the prognosis is grave,” said Peter Nielsen, President and Chief Executive Officer of Bio-Path Holdings. “The data showed prexigebersen...

Gross profit increases 178% compared to the same period last year New online store providing greater interaction with dentists and improved margins Medical division reports positive reimbursement from first commercial payers ROSELAND, N.J., Aug. 15, 2023 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the second quarter ended June 30, 2023. Arjan Haverhals, CEO and President of Milestone Scientific, stated, “I am pleased to report that we achieved strong year-over-year and sequential revenue growth for the second quarter of 2023. Revenue for the second quarter increased 77% to $2.9 million, while gross profit increased 178% over the same period...

MISSISSAUGA, Ontario, Aug. 15, 2023 (GLOBE NEWSWIRE) — Next Hydrogen Solutions Inc. (the “Company” or “Next Hydrogen“) (TSXV:NXH, OTC:NXHSF), a designer and manufacturer of electrolyzers, is pleased to report its financial results for the second quarter ended June 30, 2023. “The focus for 2023 is to (1) launch our second-generation product line with better energy efficiency, lower cost and improved reliability, (2) Demonstration our second-generation electrolyzer in a market application, and (3) demonstrate market traction for our product line with our strategic partners,” said Raveel Afzaal, President and CEO of Next Hydrogen. “We are achieving excellent results for our second-generation product line in our pilot scale facility. Further, we have on-boarded six industry partners this which gives us confidence in our go-to market...

2023 Guidance Remains on Track for Revenue up 59%-74% to $43 million-$47 million, Driving Positive Operating Income, Cash Flow and Adjusted EBITDA BATAVIA, Ill., Aug. 15, 2023 (GLOBE NEWSWIRE) —  High Wire Networks, Inc. (OTCQB: HWNI), a leading global provider of managed cybersecurity and technology enablement, reported results for continuing operations for the three and six months ended June 30, 2023. All comparisons are to the same year-ago period unless otherwise noted. Financial HighlightsFirst half 2023 revenue increased 32% to $16.1 million. Monthly recurring revenue exceeded a record $1 million. Total contract value (TCV) for Overwatch managed cybersecurity services totaled $6.0 million at quarter end, up from $5.1 million at the end of the previous quarter (see TCV defined below). Project delivery backlog of the company’s...

– Q2 23 Gross Revenue of ~$708M1, 112% of Q2 2022– Q2 23 Net Revenue of ~$56.8M1, 124% of Q2 2022– Q2 23 Adjusted EBITDA of $4.4M1, 118% of Q2 2022– Increases 2023 Net Revenue Guidance to $245-$250M, representing 155% of 2022 at midpoint AUSTIN, Texas, Aug. 15, 2023 (GLOBE NEWSWIRE) — Mondee Holdings, Inc. (Nasdaq: MOND) (“Mondee” or the “Company”), the high-growth, travel technology company and marketplace, with a portfolio of globally recognized platforms in the leisure and corporate travel sectors, today announced second quarter business milestones and financial results for the period ended June 30, 2023. “Mondee is once again disrupting the travel market through innovation. We are thrilled that on the first anniversary of our NASDAQ public listing, Mondee released the first fully integrated AI Travel...

– Continued operational execution across pipeline towards multiple clinical and regulatory value-driving milestones expected in the second half of 2023 – Company to host conference call and webcast today at 8:30 AM ET OCALA, Fla., Aug. 15, 2023 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today reported its financial results for the second quarter 2023 and provided a business update. As previously announced, the Company will host a conference call and audio webcast on Tuesday, August 15, 2023, at 8:30 AM ET (details below). “Over the course of the second quarter, our team continued to deliver on our timelines and made significant progress advancing Ampligen® through our active human clinical studies in multiple indications. We continue to be encouraged by the growing body of positive and...